LeMed Specialty Pharmacy

Name

LeMed Specialty Pharmacy

Legal name

LeMed Specialty Pharmacy

Website

https://lemedrx.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Specialty Pharmacy

NAICS

Pharmacies and Drug Retailers (456110)

SIC

Retail-Drug Stores And Proprietary Stores (5912)

akta.pro primary industry

Specialty Pharmacies (Complex/High-Cost Therapies) (HLAFALAC)

akta.pro secondary industry

Specialty Pharmacy & Complex Therapy Management Platforms (HLACAKAG)

Keywords

• Specialty pharmacy services
• Organ transplant medications
• Orphan rare disease pharmacy
• Medication therapy management
• Patient care coordination

Headquarters

HQ city

Bronx

HQ country

United States

HQ region

North America

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Marketing or Sales, Infrastructure, Technology or R&D, Others

Revenue model

1. Specialty Pharmacy Dispensing: LeMed generates revenue through dispensing specialty medications to patients, primarily for complex conditions including organ transplant, orphan and rare diseases. Services include free courier or overnight delivery, adherence packaging, and ongoing patient support.
2. Manufacturer Partnership Services: Bespoke patient care and program design services provided to pharmaceutical manufacturers through dedicated therapy care teams, data integrations, and optimized outcomes programs.
3. Payor/Health Plan Services: Integrated care management approach supporting payers and plan sponsors with individualized 24/7 care coordination and clinical support for members.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels5 records

Core offering

LeMed Specialty Pharmacy is an independent specialty pharmacy dispensing high-complexity medications for organ transplant and orphan/rare disease patients. Core services include prior authorization support, financial and co-pay assistance, adherence packaging, 24/7 pharmacist access, and nationwide home delivery across all 50 states plus Puerto Rico.

Product overview

LeMed Specialty Pharmacy operates as a single integrated specialty pharmacy platform providing comprehensive pharmaceutical care services. The core offering centers on specialty pharmacy services with dedicated therapeutic areas for Organ Transplant and Orphan & Rare Disease support, encompassing five specific rare conditions (Alkaptonuria, Hereditary Angioedema, Phenylketonuria, Primary Periodic Paralysis, and Sickle Cell Disease). Supporting these clinical areas are integrated service modules including Financial Assistance, Patient Management, Prescriber Support, Payor Care Management, and Manufacturer Partnership Services—all unified under a patient-centric care coordination model. The pharmacy holds dual specialty accreditations and maintains bi-coastal operations with nationwide licensure enabling shipping to all 50 states and Puerto Rico.

Differentiator

Problem solved

Functional benefit

Products and services

• Specialty Pharmacy Dispensing Services

Quantifiable outcome

• Up to 97% reduction in urinary homogentisic acid (HGA) with HARLIKU treatment
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Two partnerships are on record, tiered core.

• Free Market HealthcoreTechnology or Integration · 4 November 2025Strategic collaboration with Free Market Health to enhance access to rare disease therapies. LeMed leverages FMH's innovative technology platform including specialty patient onboarding technology, real-time payer policy navigation tools, AI-powered prior authorization form auto-completion, EMR data integration, and electronic PA submission for faster, more reliable approvals. This partnership eliminates manual inefficiencies and physician dependencies that often delay therapy initiation.
• Cycle PharmaceuticalscoreStrategic or Co-development Partner · 21 July 2025Cycle Pharmaceuticals selected LeMed as the exclusive U.S. specialty pharmacy distribution and services partner for HARLIKU (nitisinone) Tablets, the first and only FDA-approved treatment for reducing urinary homogentisic acid (HGA) in adults with Alkaptonuria (AKU). LeMed manages commercial and non-commercial dispensing for HARLIKU across the United States. The partnership also supports patients living with hereditary angioedema (HAE), phenylketonuria (PKU), and primary periodic paralysis (PPP).

Scale indicators6 records

Recent moves5 records

Expansion highlights5 records

Direct peers

• PANTHERx Rare Pharmacy: Independent U.S. specialty pharmacy focused specifically on rare and ultra-rare disease therapies, with exclusive and limited-distribution partnerships across multiple orphan categories — directly comparable to LeMed's positioning, accent on ultra-rare therapy areas, and bi-coastal/URAC-accredited operations.
• Diplomat Pharmacy (now Optum Specialty): Was an independent specialty pharmacy with strong rare-disease focus before its acquisition by Optum; provides a near-perfect analogous business model to LeMed (independent rare-disease specialty pharmacy) and illustrates both the path and the exit risk from PBM vertical integration.
• US Bioservices (AmerisourceBergen / Cencora): Specialty pharmacy focused on chronic, rare, and complex conditions, part of Cencora (formerly AmerisourceBergen). Comparable in clinical service model and rare-disease focus, but backed by a global pharmaceutical distributor.
• Soleo Health: Specialty pharmacy and home infusion provider serving patients with complex conditions including rare and chronic diseases. Comparable to LeMed in patient-centric care coordination, clinical pharmacist access, and manufacturer service offerings.
• Nufactor: Specialty pharmacy focused on chronic inflammatory and rare diseases with home infusion and direct-to-patient dispensing. Comparable in high-touch, condition-specific specialty pharmacy service model and reliance on prescriber relationships.
• Amber Pharmacy (now Hy-Vee Specialty Pharmacy): Specialty pharmacy serving patients with chronic, complex, and rare conditions, acquired and now operated by Hy-Vee. Comparable in independent specialty pharmacy origins, rare-disease focus, and payor/manufacturer service offerings.

Broad incumbents

• Accredo (Express Scripts / Evernorth): Largest U.S. specialty pharmacy by volume, owned by Express Scripts / Evernorth. Operates across all major specialty therapy areas including rare diseases, and is the primary PBM-affiliated competitor LeMed must differentiate against on independence and rare-disease depth.
• CVS Specialty (Caremark): Specialty pharmacy arm of CVS Health, vertically integrated with Caremark PBM. A large incumbent competitor across both specialty and rare-disease dispensing, and a key reason independent specialty pharmacies like LeMed emphasize non-PBM affiliation.
• Optum Specialty Pharmacy (OptumRx): Specialty pharmacy subsidiary of OptumRx / UnitedHealth Group, one of the largest U.S. specialty pharmacy operations. Directly competes with LeMed for manufacturer limited-distribution contracts and is a primary driver of network-access pressure on independent specialty pharmacies.
• Biologics by McKesson: Specialty pharmacy within McKesson focused on oncology, immunology, and rare-disease therapies. Comparable to LeMed in dispensing high-cost specialty medications and serving manufacturer needs, but benefits from McKesson-scale distribution and contracting.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/10345036
• Xx.com/LemedSP

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about LeMed Specialty Pharmacy